Spruce Biosciences
SPRB
40 hedge funds and large institutions have $313M invested in Spruce Biosciences in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 6 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 12
11% less funds holding
Funds holding: 45 → 40 (-5)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
32% less capital invested
Capital invested by funds: $459M → $313M (-$146M)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$3.61M |
| 2 |
Morgan Stanley
New York
|
+$593K |
| 3 |
BlackRock
New York
|
+$272K |
| 4 |
Goldman Sachs
New York
|
+$255K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$232K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$1.06M |
| 2 |
Millennium Management
New York
|
-$1.06M |
| 3 |
AIC
AWM Investment Company
New York
|
-$972K |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$812K |
| 5 |
ZP
Zimmer Partners
New York
|
-$486K |
SPRB Hedge Fund Activity: Q1 2021 in Review
40 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Spruce Biosciences (SPRB) for Q1 2021, worth a combined $313M — down 32% from $459M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of SPRB and 1 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 14 added.
The largest buyer was Sio Capital Management, adding an estimated $3.61M. The largest seller was Rock Springs Capital Management, cutting an estimated $1.06M.
- 40 institutional investors held Spruce Biosciences (SPRB) as of Q1 2021, down from 45 in Q4 2020.
- Funds reported $313M of Spruce Biosciences stock for Q1 2021, down 32% quarter-over-quarter.
- 1 fund opened new Spruce Biosciences positions in Q1 2021 and 6 closed out, a net change of -5 holders.
- The largest Spruce Biosciences buyer in Q1 2021 was Sio Capital Management, an estimated $3.61M added.
- The largest Spruce Biosciences seller in Q1 2021 was Rock Springs Capital Management, an estimated $1.06M sold.
Based on aggregated 13F filings for Q1 2021.